Allarity Therapeutics Denmark ApS: Financial statements 2018
CVR: 38445928
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Allarity Therapeutics Denmark ApS (CVR 38445928) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -348,971 and a net result of DKK -169,894 compared with DKK 339 the year before. Equity in the 2018 report amounted to DKK 2,905,745. The solvency ratio was 29.8%.
- Gross Profit
- DKK -348,971
- Profit/Loss
- DKK -169,894
- Equity
- DKK 2,905,745
- Total Assets
- DKK 9,734,569
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of December 11, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Allarity Therapeutics Denmark ApS.
As of December 11, 2018, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Allarity Therapeutics Denmark ApS.
As of December 11, 2018, Thomas Henrik Jensen has left the board of directors of Allarity Therapeutics Denmark ApS.
As of December 11, 2018, Peter Buhl has left the board of directors of Allarity Therapeutics Denmark ApS.
As of December 11, 2018, Ulla Hald Buhl has left the board of directors of Allarity Therapeutics Denmark ApS.
Allarity Therapeutics Denmark ApS has published its interim report for the period February 13, 2017 to December 31, 2017.
About Allarity Therapeutics Denmark ApS
Allarity Therapeutics Denmark ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named OV-SPV2 ApS. The management consists of Steen Meier Knudsen and Jeffrey Stuart Ervin. The company is owned by Allarity Acquisition Subsidiary, Inc.. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 174,000 the year before. Equity in the 2025 report amounted to DKK -2,476,000.
